RAD51 and neoplasm: In conclusion, our integrated multiomics and experimental analysis establishes a foundational framework in which RAD51 acts as a central oncogenic driver in OSCC, promoting tumour progression through regulation of cell proliferation, invasion, chemoresistance and immune evasion.